Anavex Life Sciences
AVXL
#7563
Rank
HK$3.06 B
Marketcap
HK$34.25
Share price
-1.12%
Change (1 day)
-42.08%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -HK$0.41 Billion

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.41 Billion a decrease over its 2023 earnings that were of -HK$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.41 Billion1.08%
2024 -HK$0.41 Billion14.77%
2023 -HK$0.35 Billion-17.49%
2022 -HK$0.43 Billion22.96%
2021 -HK$0.35 Billion35.36%
2020 -HK$0.26 Billion12.65%
2019 -HK$0.23 Billion29.09%
2018 -HK$0.18 Billion36.33%
2017 -HK$0.13 Billion17.11%
2016 -HK$0.11 Billion20.91%
2015 -HK$90.71 Million-6.29%
2014 -HK$96.8 Million337.28%
2013 -HK$22.14 Million
2008 -HK$40.94 Million106.01%
2007 -HK$19.88 Million8848.98%
2006 -HK$0.23 Million-79.99%
2005 -HK$1.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
HK$0.51 B-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-HK$51.52 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$0.51 B-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$0.14 Billion-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA